(H-3)-SEROTONIN UPTAKE SENSITIVITY TO IMIPRAMINE AND TRAZODONE IN ENDOGENOUS DEPRESSED-PATIENTS DURING ANTIDEPRESSANT TREATMENT

被引：0
|
作者：
KATASONOV, AB
BELYAEV, BS
ZLOBINA, GP
FACTOR, MI
BRUSOV, OS
机构：
来源：
ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 1989年 / 89卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：125 / 128
页数：4
相关论文
共 50 条
  • [41] PLATELET ALPHA-2-NORADRENERGIC AND IMIPRAMINE BINDING IN DEPRESSED-PATIENTS, BEFORE AND DURING TREATMENT
    THEODOROU, AE
    KATONA, CLE
    DAVIES, SL
    TUNNICLIFFE, C
    HALE, AS
    HORTON, RW
    PAYKEL, ES
    KELLY, JS
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 20 (05) : P528 - P528
  • [42] PLATELET 5-HT UPTAKE SITES, LABELED WITH [H-3] PAROXETINE, IN CONTROLS AND DEPRESSED-PATIENTS BEFORE AND AFTER TREATMENT WITH FLUOXETINE OR LOFEPRAMINE
    LAWRENCE, KM
    KATONA, CLE
    ABOUSALEH, MT
    ROBERTSON, MM
    NAIRAC, BL
    EDWARDS, DRL
    LOCK, T
    BURNS, RA
    HARRISON, DA
    HORTON, RW
    [J]. PSYCHOPHARMACOLOGY, 1994, 115 (1-2) : 261 - 264
  • [43] MODIFICATION OF CATECHOLAMINES AND SEROTONIN UPTAKE AND RELEASE AFTER CARPIPRAMINE OR METAPRAMINE CHRONICAL TREATMENT - RELATION WITH H-3 IMIPRAMINE BINDING
    DAGONNEAU, H
    FONLUPT, P
    PACHECO, H
    [J]. COMPTES RENDUS DES SEANCES DE LA SOCIETE DE BIOLOGIE ET DE SES FILIALES, 1986, 180 (01): : 43 - 48
  • [44] NITROIMIPRAMINES - SYNTHESIS AND PHARMACOLOGICAL EFFECTS OF POTENT LONG-ACTING INHIBITORS OF [H-3] SEROTONIN UPTAKE AND [H-3] IMIPRAMINE BINDING
    REHAVI, M
    ITTAH, Y
    SKOLNICK, P
    RICE, KC
    PAUL, SM
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1982, 320 (01) : 45 - 49
  • [45] INHIBITION OF SODIUM-DEPENDENT [H-3]IMIPRAMINE BINDING IN RAT-BRAIN BY SEROTONIN AND SEROTONIN UPTAKE INHIBITORS
    HRDINA, PD
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 148 (02) : 279 - 282
  • [46] PLATELET H-3 IMIPRAMINE AND H-3 PAROXETINE BINDING DURING TREATMENT WITH PSYCHOACTIVE-DRUGS
    MELLERUP, ET
    DAM, H
    LAURITZEN, L
    PLENGE, P
    [J]. BIOLOGICAL PSYCHIATRY, 1991, 30 (10) : 1056 - 1058
  • [47] USE OF SYNTHESIS INHIBITORS IN DEFINING A ROLE FOR BIOGENIC-AMINES DURING IMIPRAMINE TREATMENT IN DEPRESSED-PATIENTS
    SHOPSIN, B
    GERSHON, S
    GOLDSTEIN, M
    FRIEDMAN, E
    WILK, S
    [J]. PSYCHOPHARMACOLOGY COMMUNICATIONS, 1975, 1 (02) : 239 - 249
  • [48] CHANGES IN PLATELET H-3-IMIPRAMINE BINDING IN DEPRESSED-PATIENTS RECEIVING ELECTROCONVULSIVE-THERAPY
    MAJ, M
    MASTRONARDI, P
    CERRETA, A
    ROMANO, M
    MAZZARELLA, B
    KEMALI, D
    [J]. BIOLOGICAL PSYCHIATRY, 1988, 24 (04) : 469 - 472
  • [49] SELECTIVE LABELING OF SEROTONIN UPTAKE SITES IN RAT-BRAIN BY [H-3] CITALOPRAM CONTRASTED TO LABELING OF MULTIPLE SITES BY [H-3] IMIPRAMINE
    DAMATO, RJ
    LARGENT, BL
    SNOWMAN, AM
    SNYDER, SH
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1987, 242 (01): : 364 - 371
  • [50] SUBCELLULAR-DISTRIBUTION OF HIGH-AFFINITY [H-3]IMIPRAMINE BINDING AND [H-3]-LABELED SEROTONIN UPTAKE IN RAT-BRAIN
    REHAVI, M
    SKOLNICK, P
    PAUL, SM
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 87 (2-3) : 335 - 339
12345